Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

Clinical trial NCT00113971 · TERMINATED

Trial details

NCT number: NCT00113971
Sponsor: UCB Pharma
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2005-04-01
Primary completion: 2007-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.